SG11201405866VA - Topically administered strontium-containing complexes for treating pain, pruritis and inflammation - Google Patents
Topically administered strontium-containing complexes for treating pain, pruritis and inflammationInfo
- Publication number
- SG11201405866VA SG11201405866VA SG11201405866VA SG11201405866VA SG11201405866VA SG 11201405866V A SG11201405866V A SG 11201405866VA SG 11201405866V A SG11201405866V A SG 11201405866VA SG 11201405866V A SG11201405866V A SG 11201405866VA SG 11201405866V A SG11201405866V A SG 11201405866VA
- Authority
- SG
- Singapore
- Prior art keywords
- pruritis
- inflammation
- treating pain
- topically administered
- containing complexes
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title 1
- 208000002193 Pain Diseases 0.000 title 1
- 208000003251 Pruritus Diseases 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 229910052712 strontium Inorganic materials 0.000 title 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261613923P | 2012-03-21 | 2012-03-21 | |
| PCT/US2013/032608 WO2013142383A1 (en) | 2012-03-21 | 2013-03-15 | Topically administered strontium-containing complexes for treating pain, pruritis and inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201405866VA true SG11201405866VA (en) | 2014-10-30 |
Family
ID=49223278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201405866VA SG11201405866VA (en) | 2012-03-21 | 2013-03-15 | Topically administered strontium-containing complexes for treating pain, pruritis and inflammation |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US9333185B2 (he) |
| EP (1) | EP2827847B1 (he) |
| JP (1) | JP6163633B2 (he) |
| KR (1) | KR101729096B1 (he) |
| CN (1) | CN104363901B (he) |
| AU (1) | AU2013235345B2 (he) |
| BR (1) | BR112014023473B1 (he) |
| CA (2) | CA3026687A1 (he) |
| ES (1) | ES2930524T3 (he) |
| HK (1) | HK1204266A1 (he) |
| IL (1) | IL234701B (he) |
| MX (1) | MX351698B (he) |
| PH (1) | PH12014502093A1 (he) |
| RU (1) | RU2605279C2 (he) |
| SG (1) | SG11201405866VA (he) |
| WO (1) | WO2013142383A1 (he) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013235345B2 (en) | 2012-03-21 | 2016-03-24 | Galleon Labs Llc | Topically administered strontium-containing complexes for treating pain, pruritis and inflammation |
| WO2016130686A1 (en) * | 2015-02-11 | 2016-08-18 | Cosmederm Bioscience, Inc. | Stable high concentration strontium compounds and formulations for topical application |
| WO2016141219A1 (en) * | 2015-03-05 | 2016-09-09 | Cosmederm Bioscience, Inc. | Strontium based compositions and formulations for pain, pruritus, and inflammation |
| US20170049807A1 (en) * | 2015-08-21 | 2017-02-23 | Cosmederm Bioscience, Inc. | Strontium based compositions and formulations for pain, pruritus, and inflammation |
| US20170157169A1 (en) * | 2015-08-21 | 2017-06-08 | Cosmederm Bioscience, Inc. | Strontium based compositions and formulations for pain, pruritus, and inflammation |
| US11235002B2 (en) | 2015-08-21 | 2022-02-01 | Galleon Labs Llc | Strontium based compositions and formulations for pain, pruritus, and inflammation |
| KR101651605B1 (ko) * | 2015-12-10 | 2016-08-26 | 대봉엘에스 주식회사 | 신규 페놀산류 유도체 화합물, 및 이의 용도 |
| EP3284462B1 (en) * | 2016-08-17 | 2022-08-03 | Galleon Labs LLC | Strontium based compositions and formulations for pain, pruritus, and inflammation |
| KR101782966B1 (ko) * | 2017-03-14 | 2017-09-28 | 전북대학교산학협력단 | 가려움증의 예방 또는 치료용 조성물 |
| US10559492B2 (en) | 2017-11-15 | 2020-02-11 | Taiwan Semiconductor Manufacturing Company, Ltd. | Patterning methods for semiconductor devices and structures resulting therefrom |
| WO2020037114A1 (en) * | 2018-08-17 | 2020-02-20 | Galleon Labs Llc | Compositions and methods for the modulation of cytokines |
| US20220257561A1 (en) * | 2019-06-07 | 2022-08-18 | Advanced Delivery Labs Llc | Compositions and methods for improving wellness |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB487094A (en) | 1937-05-24 | 1938-06-15 | Niro Atomizer As | Improved method of producing milk powder preparations |
| US3833732A (en) | 1973-05-24 | 1974-09-03 | Miles Lab | Method of treating inflammation utilizing alkyl esters of gallic acid |
| US4477439A (en) | 1981-04-13 | 1984-10-16 | Walter J. Monacelli | Treatment of irritated and excoriated areas around the stoma of ostomy patients |
| GB2180153A (en) | 1985-09-10 | 1987-03-25 | Rory Ltd | Compositions containing acetylcysteine |
| AU618517B2 (en) | 1986-12-23 | 1992-01-02 | Eugene J. Van Scott | Additives enhancing topical actions of therapeutic agents |
| US6051609A (en) | 1997-09-09 | 2000-04-18 | Tristrata Technology, Inc. | Additives enhancing the effect of therapeutic agents |
| FR2728166A1 (fr) | 1994-12-19 | 1996-06-21 | Oreal | Composition topique contenant un antagoniste de substance p |
| US5716625A (en) | 1994-12-21 | 1998-02-10 | Cosmederm Technologies | Formulations and methods for reducing skin irritation |
| US7404967B2 (en) | 1994-12-21 | 2008-07-29 | Cosmederm, Inc. | Topical product formulations containing strontium for reducing skin irritation |
| US5804203A (en) | 1994-12-21 | 1998-09-08 | Cosmederm Technologies | Topical product formulations containing strontium for reducing skin irritation |
| EP0737471A3 (fr) | 1995-04-10 | 2000-12-06 | L'oreal | Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue |
| FR2740341B1 (fr) | 1995-10-26 | 1997-12-19 | Oreal | Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau |
| US6808716B2 (en) | 1999-01-08 | 2004-10-26 | Ruey J. Yu | N-acetylamino acids, related N-acetyl compounds and their topical use |
| EP1212052B1 (en) | 1999-09-14 | 2005-04-13 | Tepha, Inc. | Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| NO20014746D0 (no) * | 2001-09-28 | 2001-09-28 | Clas M Kjoelberg | Smertelindrende middel |
| JP3947149B2 (ja) * | 2002-10-28 | 2007-07-18 | 高砂香料工業株式会社 | 消臭剤組成物 |
| JP2006518751A (ja) | 2003-02-20 | 2006-08-17 | サンタラス インコーポレイティッド | 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物 |
| US8916050B2 (en) | 2004-09-27 | 2014-12-23 | Special Water Patents B.V. | Methods and compositions for treatment of water |
| GB2423928B (en) | 2004-11-16 | 2008-04-09 | Efflux Technology Inc | Methods and compositions for treating pain |
| US20080096872A1 (en) | 2004-12-22 | 2008-04-24 | Friedman Robert S | Composition for Treatment of Pain Specification |
| US20060236470A1 (en) | 2005-03-29 | 2006-10-26 | Sabnis Ram W | Novelty compositions with color changing indicator |
| US20090099154A1 (en) | 2005-06-29 | 2009-04-16 | Panacea Biotec Ltd. | Pharmaceutical Sustained Release Compositions and Processes Thereof |
| US20070134232A1 (en) | 2005-12-14 | 2007-06-14 | Joel Studin | Topical bite care composition |
| US8158608B2 (en) | 2006-03-30 | 2012-04-17 | Council Of Scientific And Industrial Research | Bioactive fraction from Zingier officinale and a process for the preparation thereof |
| EP2155769B1 (en) | 2007-05-04 | 2012-06-27 | Katholieke Universiteit Leuven KU Leuven Research & Development | Tissue degeneration protection |
| US20100226987A1 (en) | 2007-06-28 | 2010-09-09 | Capsutech Ltd. | Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers |
| NZ555022A (en) | 2007-11-07 | 2010-09-30 | Encoate Holdings Ltd | Stabilisation of dried biological material with oil and biopolymer |
| US20110129433A1 (en) | 2008-06-26 | 2011-06-02 | Ironwood Pharmaceuticals, Inc. | Compositions and Methods for Treating or Preventing Gastrointestinal Disorders and GERD-Related Respiratory Disorders |
| JP2012515721A (ja) * | 2009-01-20 | 2012-07-12 | シグナム バイオサイエンシーズ， インコーポレイテッド | 抗炎症性複合体 |
| CN102970963A (zh) | 2010-05-05 | 2013-03-13 | 莱雅公司 | 含有丙烯酸增稠剂的美容组合物 |
| EP2508168A1 (en) | 2011-04-06 | 2012-10-10 | The Procter and Gamble Company | Cosmetic composition comprising polymer comprising direct crosslinks |
| US8722040B2 (en) | 2011-06-24 | 2014-05-13 | Liveleaf, Inc. | Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites |
| AU2013235345B2 (en) | 2012-03-21 | 2016-03-24 | Galleon Labs Llc | Topically administered strontium-containing complexes for treating pain, pruritis and inflammation |
| US9480704B2 (en) * | 2012-03-21 | 2016-11-01 | Cosmederm Bioscience, Inc. | Topically administered strontium-containing complexes for treating pain, pruritis and inflammation |
| WO2015048153A1 (en) | 2013-09-24 | 2015-04-02 | Cosmederm Bioscience, Inc. | Strontium-containing complexes for treating gastroesophageal reflux and barrett's esophagus |
| WO2016090029A1 (en) | 2014-12-05 | 2016-06-09 | Briggs & Stratton Corporation | Pressure washers including jet pumps |
| WO2016130686A1 (en) | 2015-02-11 | 2016-08-18 | Cosmederm Bioscience, Inc. | Stable high concentration strontium compounds and formulations for topical application |
| WO2016141219A1 (en) | 2015-03-05 | 2016-09-09 | Cosmederm Bioscience, Inc. | Strontium based compositions and formulations for pain, pruritus, and inflammation |
| US20170049807A1 (en) | 2015-08-21 | 2017-02-23 | Cosmederm Bioscience, Inc. | Strontium based compositions and formulations for pain, pruritus, and inflammation |
| US20170157169A1 (en) | 2015-08-21 | 2017-06-08 | Cosmederm Bioscience, Inc. | Strontium based compositions and formulations for pain, pruritus, and inflammation |
| US11235002B2 (en) | 2015-08-21 | 2022-02-01 | Galleon Labs Llc | Strontium based compositions and formulations for pain, pruritus, and inflammation |
-
2013
- 2013-03-15 AU AU2013235345A patent/AU2013235345B2/en active Active
- 2013-03-15 RU RU2014142259/15A patent/RU2605279C2/ru active
- 2013-03-15 SG SG11201405866VA patent/SG11201405866VA/en unknown
- 2013-03-15 CA CA3026687A patent/CA3026687A1/en not_active Abandoned
- 2013-03-15 MX MX2014011382A patent/MX351698B/es active IP Right Grant
- 2013-03-15 CN CN201380025661.3A patent/CN104363901B/zh active Active
- 2013-03-15 JP JP2015501824A patent/JP6163633B2/ja active Active
- 2013-03-15 EP EP13764092.6A patent/EP2827847B1/en active Active
- 2013-03-15 US US14/386,731 patent/US9333185B2/en active Active
- 2013-03-15 WO PCT/US2013/032608 patent/WO2013142383A1/en active Application Filing
- 2013-03-15 KR KR1020147029206A patent/KR101729096B1/ko active IP Right Grant
- 2013-03-15 ES ES13764092T patent/ES2930524T3/es active Active
- 2013-03-15 BR BR112014023473-6A patent/BR112014023473B1/pt active IP Right Grant
- 2013-03-15 CA CA2867439A patent/CA2867439C/en active Active
-
2014
- 2014-09-17 IL IL234701A patent/IL234701B/he active IP Right Grant
- 2014-09-22 PH PH12014502093A patent/PH12014502093A1/en unknown
-
2015
- 2015-05-19 HK HK15104760.3A patent/HK1204266A1/xx unknown
-
2016
- 2016-10-04 US US15/284,892 patent/US10159693B2/en active Active
-
2018
- 2018-11-13 US US16/189,578 patent/US10874689B2/en active Active
-
2020
- 2020-11-20 US US17/100,652 patent/US11801261B2/en active Active
-
2023
- 2023-10-16 US US18/487,938 patent/US20240041919A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1204266A1 (en) | Topically administered strontium-containing complexes for treating pain, pruritis and inflammation | |
| IL289300A (he) | טיפול משולב לטיפול בסרטן | |
| HRP20181364T8 (hr) | Aminotriazolopiridin, namijenjen upotrebi u liječenju upale, te njegovi farmacetski pripravci | |
| EP2558101A4 (en) | TOPICAL PAIN TREATMENTS | |
| PL2964308T3 (pl) | Zintegrowany przeciwdrobnoustrojowy opatrunek dla pokrycia cewnika | |
| EP2819703A4 (en) | TREATMENT OF PAIN | |
| IL240599A0 (he) | טיפול משולב לטיפול בהיווצרות שאת | |
| HK1224184A1 (zh) | 用於治療炎性疾病的化合物、藥物組合物和方法 | |
| GB2525517B (en) | Topical preparation for pain relief | |
| EP2861239A4 (en) | TOPICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC SKIN INFLAMMATORY DISEASES | |
| EP2823825A4 (en) | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER | |
| EP2854786A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLAMMATION AND PAIN | |
| EP2969008A4 (en) | MEDICATION FOR THE TREATMENT OF CANCER, CARDIOVASCULAR DISEASES AND INFLAMMATION | |
| EP2854785A4 (en) | PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION AND PAIN | |
| EP2858634A4 (en) | COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND PAIN | |
| PL2617412T3 (pl) | Kompozycja do leczenia miejscowego | |
| EP2905278A4 (en) | HETEROAROMATIC COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL COMPOSITIONS, USES AND METHOD FOR THE TREATMENT OF ACUTE AND CHRONIC PAIN | |
| EP2846807A4 (en) | METHOD AND COMPOUNDS FOR THE INHIBITION OF THE MCM COMPLEX AND THEIR APPLICATION IN ANTICANCER TREATMENT | |
| IL225613A0 (he) | פורמולציה קוסמטית לטיפול מקומי בעור | |
| EP2861228A4 (en) | COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND PAIN | |
| IL237227A0 (he) | 520 –arry לשימוש בטיפול בסרטן בחולה עם aag נמוך | |
| EP2902027A4 (en) | ACTIVE COMPOSITION FOR THE TREATMENT OF TUMORS AND THE USE THEREOF | |
| HK1210693A1 (en) | Topical drug for treating aphthae | |
| GB201204364D0 (en) | Topical treatment of wounds | |
| GB201202550D0 (en) | Non Invasive Cancer Treatment |